Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 12, 2022

SELL
$126.46 - $235.05 $191,333 - $355,630
-1,513 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$225.82 - $368.51 $13,323 - $21,742
59 Added 4.06%
1,513 $384,000
Q3 2021

Nov 03, 2021

BUY
$221.9 - $484.47 $34,172 - $74,608
154 Added 11.85%
1,454 $560,000
Q2 2021

Aug 13, 2021

BUY
$129.91 - $234.98 $168,883 - $305,474
1,300 New
1,300 $305,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Crestwood Advisors Group LLC Portfolio

Follow Crestwood Advisors Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.